|
|
|
|
|
|
Sponsored by: |
Memorial Sloan-Kettering Cancer Center |
Information provided by: | Memorial Sloan-Kettering Cancer Center |
ClinicalTrials.gov Identifier: | NCT00745355 |
The purpose of this study is to learn about the quality of life of people living with invasive bladder cancer. We are interested in learning about how the treatments for bladder cancer affect people. We plan to use the findings from this study to help doctors provide better care and information to patients with invasive bladder cancer.
Condition | Intervention |
Bladder Cancer |
Behavioral: Quality Of Life questionnaires |
Genetics Home Reference related topics: | bladder cancer |
MedlinePlus related topics: | Bladder Cancer Cancer |
Drug Information available for: | BaseLine |
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Official Title: | A Prospective Study of Quality of Life in Patients With Invasive Bladder Cancer |
Estimated Enrollment: | 300 |
Study Start Date: | August 2008 |
Estimated Study Completion Date: | August 2011 |
Estimated Primary Completion Date: | August 2011 (Final data collection date for primary outcome measure) |
Groups/Cohorts | Assigned Interventions |
1
new patients with invasive bladder cancer and/or are scheduled for radical cystectomy and urinary diversion
|
Behavioral: Quality Of Life questionnaires
All patients who agree to participate will be interviewed using a baseline idiographic quality of life assessment prior to surgery and at approximately 6, 12, 18 and 24 months postoperatively. All patients will also be asked to respond to a questionnaire including all standard measures (closed-ended, multiple choice items) before surgery and at approximately 3, 6, 12, 18 and 24 months post-surgery.
|
Ages Eligible for Study: | 21 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
All eligible MSKCC patients.
Inclusion Criteria:
Exclusion Criteria:
Contact: Bernard Bochner, MD | bochnerb@mskcc.org | |
Contact: Bruce Rapkin, PhD | rapkinb@mskcc.org |
United States, New York | |||||
Memorial Sloan-Kettering Cancer Center | Recruiting | ||||
New York, New York, United States, 10065 | |||||
Contact: Bernard Bochner, MD bochnerb@mskcc.org | |||||
Contact: Bruce Rapkin, PhD rapkinb@mskcc.org | |||||
Principal Investigator: Bernard Bochner, MD |
Memorial Sloan-Kettering Cancer Center |
Principal Investigator: | Bernard Bochner, MD | Memorial Sloan-Kettering Cancer Center |
Memorial Sloan-Kettering Cancer Center 
  |
Responsible Party: | Memorial Sloan-Kettering Cancer Center ( Bernard Bochner, MD ) |
Study ID Numbers: | 08-076 |
First Received: | August 22, 2008 |
Last Updated: | September 2, 2008 |
ClinicalTrials.gov Identifier: | NCT00745355 |
Health Authority: | United States: Institutional Review Board |
|
|
|
|